We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$216B
AUM Growth
+$23B
Cap. Flow
+$15.2B
Cap. Flow %
7.01%
Top 10 Hldgs %
16.18%
Holding
8,493
New
749
Increased
3,978
Reduced
2,659
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 7.19%
2 Technology 6.4%
3 Healthcare 6.06%
4 Industrials 4.94%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCTY
6726
The9 Ltd
NCTY
$68.1M
$12K ﹤0.01%
40
+33
+471% +$10.2K
NDRA icon
6727
ENDRA Life Sciences
NDRA
$5.97M
0
NRC icon
6728
NRC Health Common Stock
NRC
$432M
$12K ﹤0.01%
+318
New +$9.99K
PRQR icon
6729
ProQR Therapeutics
PRQR
$243M
$12K ﹤0.01%
2,412
+646
+37% +$3.35K
PTN
6730
Palatin Technologies
PTN
$13.7M
$12K ﹤0.01%
14
+12
+600% +$7.12K
RILY icon
6731
BRC Group Holdings
RILY
$288M
$12K ﹤0.01%
+692
New +$12K
SVM
6732
Silvercorp Metals
SVM
$2.07B
$12K ﹤0.01%
4,631
-5,984
-56% -$17.3K
TACT icon
6733
Transact Technologies
TACT
$53.2M
$12K ﹤0.01%
1,200
TPST icon
6734
Tempest Therapeutics
TPST
$13.7M
$12K ﹤0.01%
3
+2
+200% +$8.55K
UL icon
6735
PUT
Unilever
UL
$137B
$12K ﹤0.01%
+178
New +$11.4K
WMS icon
6736
Advanced Drainage Systems
WMS
$10.6B
$12K ﹤0.01%
600
-9,574
-94% -$193K
XNET
6737
Xunlei
XNET
$340M
$12K ﹤0.01%
+2,780
New +$10.9K
YUMC icon
6738
PUT
Yum China
YUMC
$16.5B
$12K ﹤0.01%
300
+200
+200% +$7.45K
ZVRA icon
6739
Zevra Therapeutics
ZVRA
$562M
$12K ﹤0.01%
200
+148
+285% +$7.88K
GRDX
6740
GridAI Technologies Corp
GRDX
$20.4M
0
AINC
6741
DELISTED
Ashford Inc.
AINC
$12K ﹤0.01%
190
+189
+18,900% +$10.2K
AAU
6742
DELISTED
Almaden Minerals Ltd
AAU
$12K ﹤0.01%
10,700
-17,137
-62% -$20K
CGRN
6743
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$12K ﹤0.01%
1,652
-4,470
-73% -$28.9K
MLPY
6744
DELISTED
Morgan Stanley Cushing MLP High Income Index ETN
MLPY
$12K ﹤0.01%
1,585
+503
+46% +$3.61K
NTRP
6745
DELISTED
Neurotrope, Inc. Common
NTRP
$12K ﹤0.01%
2,353
-196
-8% -$1.03K
PSV
6746
DELISTED
Hermitage Offshore Services Ltd.
PSV
$12K ﹤0.01%
880
+583
+196% +$7.47K
CALL
6747
DELISTED
magicJack VocalTec Ltd
CALL
$12K ﹤0.01%
1,637
+1,635
+81,750% +$12K
GST
6748
DELISTED
Gastar Exploration Inc.
GST
$12K ﹤0.01%
14,009
-1,741
-11% -$1.3K
PQ
6749
DELISTED
Petroquest Energy Inc Wd
PQ
$12K ﹤0.01%
5,372
+941
+21% +$1.86K
CBMXW
6750
DELISTED
CombiMatrix Corporation Warrant
CBMXW
$12K ﹤0.01%
4,684
+4,484
+2,242% +$9.27K

Similar funds

UBS Group's Q3 2017 Portfolio in Review

As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.

  • UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
  • UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
  • UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
  • UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
  • UBS Group opened 749 new positions and closed 707 in Q3 2017.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.